GLP1R and diabetes mellitus: GLP-1R agonists are in clinical use for the treatment of diabetes and several studies indicate that they may be useful in the treatment of ischemic stroke, but the neuroprotective efficiency of orally administered low molecular weight agonists has not been reported.